Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Curative surgery for gastric cancer in a patient with an implantable left ventricular assist device

  • 195 Accesses

  • 6 Citations

Abstract

The number of patients with end-stage heart failure treated by a left ventricular assist device (LVAD) is dramatically increasing, because the LVAD has been widely accepted for its clinical results. According to the initiation of destination therapy, the prevalence of malignancy in patients with an LVAD is estimated to increase. In patients with LVADs, abdominal surgery for visceral malignancy is associated with technical difficulties because of the presence of an LVAD pump or the driveline which is located transversely in the preperitoneal space. Herein, we describe the technical management for complete resection of gastric cancer in a patient with an LVAD.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigation. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.

  2. 2.

    Schmid C, Wilhelm M, Dietl KH, Schmidt C, Hammel D, Scheld HH. Noncardiac surgery in patients with left ventricular assist devices. Surgery. 2001;129:440–4.

  3. 3.

    Eck DL, Belli EV, Smith CD, Stauffer JA. Laparoscopic cholecystectomy in patients with HeartMate II left ventricular assist devices. J Laparoendosc Adv Surg Tech A. 2014;24:100–3.

  4. 4.

    Knaus W, Olson CH. Colo-colonic anastomosis in a continuous-flow left ventricular assist device patient. Asian J Surg. 2015. doi:10.1016/j.asjsur.2015.01.003.

  5. 5.

    Sansone R, Stanske B, Keymel S, Schuler D, Horn P, Saeed D, Boeken U, Westenfeld R, Lichtenberg A, Kelm M, Heiss C. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: Role of microparticles. J Heart Lung Transpl. 2015;34:921–32.

  6. 6.

    Tatsumi E, Miyazaki K, Toda K, Takenaka Y, Nakatani T, Baba Y, Masuzawa T, Wakisaka Y, Eya K, Nishimura T, Takewa Y, Ohno T, Takano H. Influence of non-pulsatile circulation on tissue blood flow and oxygen metabolism. ASAIO J. 1996;42:M757–62.

Download references

Author information

Correspondence to Yoshiki Sawa.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose concerning this case report.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nakamura, Y., Toda, K., Nakamura, T. et al. Curative surgery for gastric cancer in a patient with an implantable left ventricular assist device. J Artif Organs 20, 170–173 (2017). https://doi.org/10.1007/s10047-016-0944-3

Download citation

Keywords

  • Ventricular assist device
  • Abdominal surgery
  • Visceral malignancy